Back to search

Netherlands· NL-f5a68fda5b68

APO-go 5 mg/ml, oplossing voor infusie in een voorgevulde spuit

A apomorphine product containing apomorfinehydrochloridehemihydraat, registered in Netherlands by Stada Arzneimittel AG. The same ATC class is registered in 10 of our 19 countries.

ATC N04BC07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAPO-go 5 mg/ml, oplossing voor infusi…ATCN04BC07REGISTER NO.NL-f5a68fda5b68PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Apomorphine is registered in 10 of 19 countries.

Countries holding a registration under ATC N04BC07 (apomorphine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Apomorphine · ATC N04BC07

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of apomorphine costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Apomorphine · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$18.87
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
APOMORFINEHYDROCHLORIDEHEMIHYDRAAT
Manufacturer
Stada Arzneimittel AG
Country
Netherlands (NL)
ATC code
N04BC07
ATC class
Apomorphine
Defined daily dose
20 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    35295

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

226 interactions on record for apomorphine.

Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Apomorphine · interactions on record

226 records

  • 41 severe
  • 182 moderate
  • 2 minor
  • 1 info

Most severe, free to view

  • PapaverineA03AD01severe
  • AlosetronA03AE01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Apomorphine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All apomorphine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Apo-Go, Apo-Go Ampullen
  • Belgium · Apo-Go ®-Cartridge, Apo-Go-Pen
  • Bulgaria · Dacepton, Апо-Гo Пнс
  • Cyprus · Apo-Go Pfs, Apo-Go Συσκευή Τύπου Πένασ
  • Czechia · Britaject, Britaject Pen
  • Germany · Apo-Go, Apo-Go Ampullen
  • Denmark · Apo-Go Pen, Apo-Go Pod
  • Estonia · Apo-Go, Dacepton
  • Spain · Apo-Go, Apo-Go Pen
  • Finland · Apogo Pen, Dacepton
  • France · Apokinon, Apomorphine Biogaran
  • United Kingdom (Northern Ireland) · Apo-Go Ampoules, Apo-Go Pen
  • Greece · Apo-Go Pfs, Apo-Go Pod
  • Croatia · Dacepton
  • Hungary · Dacepton
  • Ireland · Apo-Go Ampoules, Apo-Go Pen
  • Italy · Apofin, Dacepton
  • Lithuania · Britaject, Dacepton
  • Luxembourg · Apo-Go Ampoules, Apo-Go Pen
  • Latvia · Apo-Go, Apo-Go Pen
  • Malta · Apo-Go Pen, Apo-Go Pfs
  • Norway · Apomorfin Pharmswed, Britaject
  • Poland · Dacepton
  • Portugal · Apo-Go, Apo-Go Pen
  • Romania · Apo-Go
  • Sweden · Apo-Go, Apo-Go För Pod
  • Slovenia · Apo-Go, Dacepton
  • Slovakia · Dacepton

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/688cd37a-9b11-4451-bfce-a0ab5586912d
GET /v1/drugs/688cd37a-9b11-4451-bfce-a0ab5586912d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Subcutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h35295_smpc.pdf",
  "strength": null,
  "atc_label": "Apomorphine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg35295",
  "excipients": [
    "NATRIUMMETABISULFIET (E 223)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "APOMORFINEHYDROCHLORIDEHEMIHYDRAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h35295.pdf",
  "authorised_at": "2008/02/19",
  "procedure_number": "IE/H/0658/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "35295",
  "additional_monitoring": "N"
}

See everything about apomorphine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.